As a leading Edoxaban4-Methylbenzenesulfonate, Hydrate (1:1:1) supplier, we deliver high-quality products across diverse grades to meet evolving needs, empowering global customers with safe, efficient, and compliant chemical solutions.
What is the chemical structure of Edoxaban 4-Methylbenzenesulfonate, Hydrate (1:1:1)?
Edoxaban 4-methylbenzene sulfonate, hydrate (1:1:1), its chemical structure also needs to be studied in detail. Edoxaban, an anticoagulant drug, has its own unique structure. In the combination of (1:1:1), 4-methylbenzene sulfonate is related to it. 4-methylbenzene sulfonate, with a benzene ring connected to methyl and sulfonic acid radical groups. The benzene ring, a six-membered carbon ring, is a common basis for organic structures. Methyl (-CH) is attached to the benzene ring, which can affect its electron cloud distribution and spatial hindrance. Sulfonic acid radical group (-SO-H), with strong polarity, can increase its water solubility.
The water of the hydrate binds to edusaban and 4-methylbenzene sulfonate in a specific ratio. Water molecules or weak interactions such as hydrogen bonds are connected to edusaban and 4-methylbenzene sulfonate. The structure of edusaban itself contains specific heterocycles and functional groups, or amide bonds, nitrogen heterocycles, etc. These structures all play an important role in its anticoagulant activity. Each part is combined in this way to form a unique (1:1:1) chemical structure. The overall structural characteristics of the whole have a key impact on the stability, solubility, and activity of the drug.
What are the main uses of Edoxaban 4-Methylbenzenesulfonate, Hydrate (1:1:1)?
Edoxaban 4 - Methylbenzenesulfonate Hydrate (1:1:1) is a medicine commonly used by doctors in anticoagulation treatment.
It is effective in preventing and treating thrombosis. In patients with atrial fibrillation, it can effectively reduce the risk of stroke and systemic embolism. During atrial fibrillation, the atrium beats are disordered, which is easy to cause blood stasis and thrombosis. This drug can block the action of coagulation factors, making thrombosis difficult and protecting the patient's health.
It is also useful in the prevention and treatment of deep vein thrombosis and pulmonary embolism. After deep vein thrombosis, if the embolus falls off with the blood flow to the lungs, it can cause pulmonary embolism and endanger life. This medicine can prevent the progression and recurrence of thrombosis, promote the dissolution of the formed thrombosis, reduce the pain of the patient, and keep the blood vessels unobstructed.
After surgery, the patient's blood is often hypercoagulated and prone to thrombosis. This medicine is used for postoperative anticoagulation, which can reduce the possibility of thrombotic complications, help the patient recover smoothly after surgery, and reduce the worry of postoperative thrombosis.
When taking medication, the doctor must carefully review the patient's physique and condition to weigh the pros and cons. Because of the latent risk of causing bleeding, close monitoring is required to ensure that the medication is safe and effective to achieve the best treatment effect.
What is the production process of Edoxaban 4-Methylbenzenesulfonate, Hydrate (1:1:1)?
To prepare Edoxaban + 4 - Methylbenzenesulfonate, Hydrate (1:1:1), the preparation method is as follows:
First take the raw material of edoxaban, which is the key starting material. In a suitable reaction vessel, weigh an appropriate amount of the raw material with accurate measurement. Then, add 4 - Methylbenzenesulfonate. The ratio of the two must strictly follow 1:1, which is to ensure the accuracy of the stoichiometric ratio of the product. When adding, the action should be slow and stirred continuously, so that the two are fully mixed and contacted.
Next, control the temperature and pressure of the reaction environment. When the temperature is maintained within a certain range, this range has been determined by repeated tests and studies to promote the reaction of the two at the best rate. The pressure also needs to be stable at a certain value in order to create conditions conducive to the reaction.
During the reaction, pay close attention to the reaction process. The degree of the reaction can be monitored by specific analytical methods, such as thin-layer chromatography, high-performance liquid chromatography, etc. When the reaction reaches the expected stage, add an appropriate amount of water to form a hydrate in the system, and reach a ratio of 1:1:1. After
, the reaction product is separated and purified. First, the unreacted solid impurities are removed by filtration. Then the target product is separated from the reaction mixture by extraction with a suitable organic solvent. Subsequently, the product is further purified by recrystallization to obtain high purity Edoxaban + 4 - Methylbenzenesulfonate, Hydrate (1:1:1). The whole process requires strict control of the conditions of each step to ensure the quality and yield of the product.
What is the market outlook for Edoxaban 4-Methylbenzenesulfonate, Hydrate (1:1:1)?
Edoxaban and 4-methylbenzenesulfonate hydrate formed in 1:1 (1:1:1), its market prospect is related to the pattern of the pharmaceutical field. Looking back in the past, the coagulation drug market was mostly dominated by traditional drugs, but with the progress of medicine, the demand for new anticoagulants is increasing. Edoxaban, this hydrate, has unique pharmacological properties.
In terms of clinical advantages, its anticoagulant effect is exact, it can effectively reduce the risk of thrombosis, and it is excellent in the prevention and treatment of atrial fibrillation and other diseases. Compared with similar drugs, the bleeding risk is controllable, the safety is good, and it is convenient to take. The once-a-day dosing regimen improves patient compliance.
From a market perspective, the global aging population is increasing, the incidence of cardiovascular diseases is increasing, and the anticoagulant drug market continues to expand. With its own advantages, this hydrate is expected to gain a considerable share in the fiercely competitive market. Many pharmaceutical companies also value its potential and increase their R & D and promotion efforts.
Furthermore, the policy environment also helps it. Regulatory authorities have optimized the approval process of innovative drugs to accelerate their listing process, promote their faster benefit to patients, and also promote market expansion. Therefore, Edoxaban + 4 -methylbenzene sulfonate hydrate (1:1:1) has great potential in the future pharmaceutical market and will add new brilliance to the field of anticoagulant therapy.
What are the precautions for using Edoxaban 4-Methylbenzenesulfonate, Hydrate (1:1:1)?
Alas! When you want to use Edoxaban + 4 - Methylbenzenesulfonate, Hydrate (1:1:1), you should pay attention to many things. First of all, the dosage of the medicine must be accurate. The dosage of this medicine depends on the specific condition of the patient, such as age, weight, physical health and the characteristics of the disease. Do not change the dose to prevent poor efficacy or adverse reactions.
For the second time, the time of administration is also critical. It should be taken regularly according to the doctor's instructions, or before or after meals. If eating affects the absorption of the drug, it should be done with caution to ensure that the drug can achieve the best effect.
Furthermore, pay close attention to your own reaction during the medication. If there are symptoms such as allergies, such as rash, itching, shortness of breath; or gastrointestinal discomfort, such as nausea, vomiting, diarrhea, etc., the doctor must be informed immediately.
And during the medication process, do not mix with other drugs by yourself. Due to the occasional interaction of different drugs, or increase the risk of adverse reactions, or reduce the efficacy of the drug. If you need to use other drugs, you must consult with the doctor.
In addition, long-term users should be regularly reviewed so that the doctor can be aware of the impact of the drug on the body and adjust the treatment plan in a timely manner.
The preservation of this drug should not be ignored. It should be stored in a suitable temperature and humidity environment according to the instructions, protected from direct sunlight, moisture-proof and insect-proof, so as to ensure the quality of the drug.